Ligne de temps
Selene Di Carlo
Ingénieur(e) de Recherche
06 oct. 2023
news
New publication – Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.
Lire plus05 oct. 2023
publication
Depletion of slow-cycling PDGFRα+ADAM12+ mesenchymal cells promotes antitumor immunity by restricting macrophage efferocytosis.
Lire plus30 janv. 2023
25 janv. 2023
06 mai 2022
news
New publication – PDGFRα-induced stromal maturation is required to restrain postnatal intestinal epithelial stemness and promote defense mechanisms
Lire plus05 mai 2022
publication
PDGFRα-induced stromal maturation is required to restrain postnatal intestinal epithelial stemness and promote defense mechanisms.
Lire plus21 juil. 2019
02 janv. 2018
14 mai 2016
publication
B cells promote tumor progression in a mouse model of HPV-mediated cervical cancer
Lire plus16 juil. 2015
16 avr. 2015
20 févr. 2015
publication
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells
Lire plus06 déc. 2012
publication
Inhibition of p85, the non-catalytic subunit of phosphatidylinositol 3-kinase, exerts potent antitumor activity in human breast cancer cells
Lire plus29 juil. 2012
publication
Lineage tracing and genetic ablation of ADAM12(+) perivascular cells identify a major source of profibrotic cells during acute tissue injury
Lire plus30 juin 2009
publication
Negative regulation of beta4 integrin transcription by homeodomain-interacting protein kinase 2 and p53 impairs tumor progression
Lire plus13 févr. 2008
publication